Does PAMIDRONATE Cause Poor venous access? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Poor venous access have been filed in association with PAMIDRONATE (Pamidronate Disodium). This represents 1.5% of all adverse event reports for PAMIDRONATE.
24
Reports of Poor venous access with PAMIDRONATE
1.5%
of all PAMIDRONATE reports
3
Deaths
0
Hospitalizations
How Dangerous Is Poor venous access From PAMIDRONATE?
Of the 24 reports, 3 (12.5%) resulted in death.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAMIDRONATE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does PAMIDRONATE Cause?
Osteonecrosis of jaw (313)
Drug ineffective (180)
Pain (164)
Off label use (143)
Pyrexia (106)
Malignant neoplasm progression (103)
Dyspnoea (102)
Fatigue (97)
Pain in jaw (97)
Metastases to bone (95)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which PAMIDRONATE Alternatives Have Lower Poor venous access Risk?
PAMIDRONATE vs PAMIDRONIC ACID
PAMIDRONATE vs PANCRELIPASE
PAMIDRONATE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE
PAMIDRONATE vs PANCURONIUM
PAMIDRONATE vs PANITUMUMAB